Aclaris Therapeutics Ownership | Who Owns Aclaris Therapeutics?


OverviewForecastRevenueFinancialsChart

Aclaris Therapeutics Ownership Summary


Aclaris Therapeutics is owned by 19.64% institutional investors, 2.96% insiders, and 77.41% retail investors. Bml capital management is the largest institutional shareholder, holding 11.62% of ACRS shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.63% of its assets in Aclaris Therapeutics shares.

ACRS Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockAclaris Therapeutics19.64%2.96%77.41%
SectorHealthcare Stocks 232.64%10.66%-143.30%
IndustryDiagnostics & Research Stocks35.92%10.61%53.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Bml capital management14.25M11.62%$42.89M
Vivo capital8.89M7.25%$16.89M
Blackrock funding, inc. /de6.80M5.55%$20.48M
Vanguard group6.50M5.30%$19.57M
D. e. shaw3.29M4.61%$8.17M
Adage capital partners gp5.28M4.31%$10.03M
Rock springs capital management lp4.61M3.76%$8.76M
Decheng capital4.04M3.30%$12.17M
Blackrock2.03M2.86%$2.24M
Morgan stanley3.42M2.79%$10.28M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Bml capital management14.25M37.08%$42.89M
Aldebaran capital954.26K2.58%$2.87M
Decheng capital4.04M1.64%$12.17M
Vivo capital8.89M1.36%$16.89M
Northwestern mutual wealth management1.90M0.82%$1.30B
Three bridge wealth advisors714.82K0.57%$2.15M
Palo alto investors lp1.57M0.55%$2.98M
Rock springs capital management lp4.61M0.51%$8.76M
Aisling capital management lp434.45K0.27%$1.31M
Logos global management lp1.50M0.26%$2.85M

Top Buyers

HolderShares% AssetsChange
Northwestern mutual wealth management1.90M0.82%1.90M
Ameriprise financial1.28M0.00%1.28M
Blackrock funding, inc. /de6.80M0.00%1.11M
Adar1 capital management373.68K0.07%373.68K
Connor, clark & lunn investment management1.43M0.01%366.51K

Top Sellers

HolderShares% AssetsChange
Ra capital management---4.67M
Adage capital partners gp5.28M0.02%-4.35M
Blackrock2.03M0.00%-3.17M
Janus henderson group---2.80M
Samsara biocapital---2.39M

New Positions

HolderShares% AssetsChangeValue
Ameriprise financial1.28M0.00%1.28M$2.43B
Adar1 capital management373.68K0.07%373.68K$710.00K
Alps advisors88.97K0.00%88.97K$267.79K
American century companies31.79K-31.79K$60.40K
Valeo financial advisors27.54K0.00%27.54K$82.89K

Sold Out

HolderChange
Clearstead advisors-1.00
Nelson, van denburg & campbell wealth management group-14.00
Innealta capital-56.00
Cornerstone planning group-580.00
Federated hermes-902.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Dec 31, 202524-76.70%24,077,074-71.90%190.40%12-72.09%5-87.18%
Sep 30, 202528-68.89%24,422,115-71.00%190.42%8-84.62%11-54.17%
Jun 30, 202595-12.04%91,849,9067.52%741.54%56-9.68%25-
Mar 31, 20251106.80%92,692,4785.96%750.50%626.90%264.00%
Dec 31, 202410328.75%87,478,91971.89%1222.41%5881.25%25-

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv3.17M2.63%-
Vanguard US Total Market Shares ETF2.12M1.96%-
iShares Russell 2000 ETF2.22M1.84%963.24K
Vanguard Institutional Extnd Mkt Idx Tr1.11M0.92%4.09K
Fidelity Small Cap Index921.97K0.77%-1.10K
Xtrackers S&P 500 Swap ETF 1C916.55K0.76%-6.76K
SQUAD Aguja Opportunities I500.00K0.70%-
iShares Russell 2000 Value ETF798.85K0.66%798.85K
iShares Biotechnology ETF684.01K0.57%219.19K
Vanguard Strategic Small-Cap Equity Inv592.57K0.49%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 19, 2024Mehra Anand-Buy$1.50M
Aug 05, 2024Leonard Braden Michael-Buy$256.36K
Aug 02, 2024Leonard Braden Michael-Buy$216.40K
Jul 30, 2024Leonard Braden Michael-Buy$226.37K
Jul 31, 2024Leonard Braden Michael-Buy$132.64K

Insider Transactions Trends


DateBuySell
2026 Q1--
2025 Q4--
2025 Q3--
2025 Q2--
2025 Q1--

ACRS Ownership FAQ


Who Owns Aclaris Therapeutics?

Aclaris Therapeutics shareholders are primarily institutional investors at 19.64%, followed by 2.96% insiders and 77.40% retail investors. The average institutional ownership in Aclaris Therapeutics's industry, Diagnostics & Research Stocks, is 35.92%, which Aclaris Therapeutics falls below.

Who owns the most shares of Aclaris Therapeutics?

Aclaris Therapeutics’s largest shareholders are Bml capital management (14.25M shares, 11.62%), Vivo capital (8.89M shares, 7.25%), and Blackrock funding, inc. /de (6.8M shares, 5.55%). Together, they hold 24.42% of Aclaris Therapeutics’s total shares outstanding.

Does Blackrock own Aclaris Therapeutics?

Yes, BlackRock owns 2.86% of Aclaris Therapeutics, totaling 2.03M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 2.24M$. In the last quarter, BlackRock decreased its holdings by -3.17M shares, a -60.94% change.

Who is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested?

Bml capital management is Aclaris Therapeutics’s biggest shareholder by percentage of total assets invested, with 37.08% of its assets in 14.25M Aclaris Therapeutics shares, valued at 42.89M$.

Who is the top mutual fund holder of Aclaris Therapeutics shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Aclaris Therapeutics shares, with 2.63% of its total shares outstanding invested in 3.17M Aclaris Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools